Q4 2025 Holdings
Filed 2026-02-26 | 87 holdings | $147.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-04-02) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $62.9M | 1,515,151 | 42.6% |
| Cogent Biosciences Inc(COGT)A | COM | 19240Q201 | $7.6M | 214,099 | 5.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.0M | 130,079 | 4.1% |
| Terns Pharmaceuticals Inc(TERN)A | COM | 880881107 | $5.3M | 130,413 | 3.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.2M | 65,800 | 3.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.1M | 91,267 | 2.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $3.1M | 568,747 | 2.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $3.0M | 68,569 | 2.0% |
| Assembly Biosciences Inc(ASMB)A | COM NEW | 045396207 | $2.5M | 73,762 | 1.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $2.4M | 12,955 | 1.6% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $2.1M | 79,560 | 1.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $1.9M | 215,172 | 1.3% |
| Abivax SA(ABVX)A | SPONSORED ADS | 00370M103 | $1.8M | 13,499 | 1.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $1.7M | 109,554 | 1.1% |
| Enliven Therapeutics Inc(ELVN)A | COM | 29337E102 | $1.5M | 99,953 | 1.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $1.5M | 55,342 | 1.0% |
| Mineralys Therapeutics Inc(MLYS)A | COM | 603170101 | $1.5M | 42,025 | 1.0% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $1.5M | 9,161 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.4M | 70,180 | 0.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $1.3M | 12,601 | 0.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.2M | 5,670 | 0.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $1.2M | 82,500 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $1.2M | 25,365 | 0.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $1.2M | 63,343 | 0.8% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $1.1M | 533,648 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.1M | 1,860 | 0.7% |
| Geron Corp(GERN) | COM | 374163103 | $1.0M | 777,880 | 0.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $986.2K | 4,000 | 0.7% |
| Athira Pharma Inc(LONA) | COM | 04746L203 | $968.6K | 127,951 | 0.7% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $919.7K | 167,223 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $897.4K | 147,600 | 0.6% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $872.5K | 166,500 | 0.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $863.9K | 31,738 | 0.6% |
| Celcuity Inc(CELC)A | COM | 15102K100 | $831.6K | 8,338 | 0.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $795.8K | 2,700 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $781.9K | 48,412 | 0.5% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $769.6K | 327,500 | 0.5% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $744.3K | 154,109 | 0.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $698.7K | 8,000 | 0.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $668.4K | 3,026 | 0.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $656.7K | 10,335 | 0.4% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $634.2K | 15,000 | 0.4% |
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $633.4K | 1,300 | 0.4% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $617.6K | 73,000 | 0.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $603.8K | 14,651 | 0.4% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $574.0K | 18,200 | 0.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $545.3K | 82,000 | 0.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $542.4K | 20,600 | 0.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $461.9K | 56,750 | 0.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $456.0K | 14,654 | 0.3% |